SCHEMBL18403035

SCHEMBL18403035

CC(=O)NC[C@H]1CN(c2ccc(-c3ccc(Cn4nnc(C(N)=O)c4N)cc3)c(F)c2)C(O)O1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 4/20 0.41
▸ POLB P06746 2/20 0.37
▸ MAOB P27338 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ CALML3 P27482 1/20 0.36
▸ SDHA P31040 1/20 0.36
▸ GALR3 O60755 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ NR2F2 P24468 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ F10 P00742 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KCNH2 Q12809 1/20 0.35
▸ TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3088809 0.86 MAOA (0.57) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL21555913 0.82 MAOA (0.39) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL18402993 0.81 MAOA (0.38) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL21555906 0.79 MAOA (0.40) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL10197335 0.77 CALML3 (0.52) MAOAMAOBCALML3CYP3A4CYP2C9
SCHEMBL12075832 0.76 CALML3 (0.52) MAOAMAOBCALML3CYP3A4CYP2C9
SCHEMBL21555902 0.76 L3MBTL1 (0.41) MAOALMNACALML3F10
SCHEMBL21555918 0.75 MAOA (0.39) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL18402996 0.75 MAOA (0.42) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL3088807 0.75 CALML3 (0.45) MAOAMAOBCALML3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9550783-B2 Biaryl heterocyclic compounds and methods of making and using the same MELINTA THERAPEUTICS, INC. (US) 2017-01-24 — — US disclosed
Send feedback